EndoTech is officially launching its Copy Trading technology on a Tier 1 Exchange

EndoTech is officially launching its Copy Trading technology on a Tier 1 Exchange 🔥

This is completely separate from Daisy — this is pure EndoTech expansion 🌍

As the Daisy community, we are shareholders of EndoTech and collectively own 20% of the company 💎 That means we are not just participants… we are owners.

And yes — shareholders receive dividends every month 💰📈

Major growth. Major exposure. Major opportunity.

The next chapter is loading ⚡